SCHEMBL14059

SCHEMBL14059

NCCCN1CC[C@H](NC(N)=O)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.48
SMYD3 Q9H7B4 1/20 0.44
F2 P00734 2/20 0.42
ST14 Q9Y5Y6 2/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
PRSS3 P35030 1/20 0.42
F10 P00742 1/20 0.40
HRH2 P25021 4/20 0.39
HRH1 P35367 4/20 0.39
BCHE P06276 1/20 0.36
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
CHRM3 P20309 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
EPHX1 P07099 1/20 0.35
EPHX2 P34913 1/20 0.35
CACNA1H O95180 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14853442 1.00 LTA4H (0.48) LTA4HSMYD3F2ST14PRSS1
SCHEMBL13743 0.91 BCHE (0.43) LTA4HSMYD3F2ST14PRSS1
SCHEMBL19719305 0.83 SMYD3 (0.42) LTA4HSMYD3F2ST14PRSS1
SCHEMBL14853439 0.83 SMYD3 (0.42) LTA4HSMYD3F2ST14PRSS1
SCHEMBL17354490 0.83 SMYD3 (0.42) LTA4HSMYD3F2ST14PRSS1
SCHEMBL13781 0.81 LTA4H (0.43) LTA4HBCHECHRM3SIGMAR1CACNA1H
SCHEMBL14250 0.81 LTA4H (0.43) LTA4HBCHECHRM3SIGMAR1CACNA1H
SCHEMBL14394 0.81 LTA4H (0.43) LTA4HBCHECHRM3SIGMAR1CACNA1H
SCHEMBL14850302 0.80 CACNA1H (0.50) SMYD3F2ST14PRSS1PRSS2
SCHEMBL17485873 0.80 KDM5A (0.41) SMYD3F2ST14PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011047323-A2 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2011-04-21 WO disclosed